As only about 20% of sentinel node (SN) positive melanoma patients have additional non-
SN lymph node involvement in the Completion Lymph Node Dissection (CLND) specimen …

Purpose Approximately 20% of sentinel node (SN) positive melanoma patients have
additional non-SN (NSN) metastasis. The rationale for this study was to identify the factors …

Purpose Sentinel node biopsy is now widely accepted as the most accurate prognostic
indicator in melanoma, and is important in guiding management of patients with clinical …

Summary Background Data: The more intensive sentinel node (SN) pathologic workup, the
higher the SN-positivity rate. This is characterized by an increased detection of cases with …

Purpose We and others have demonstrated that additional positive lymph nodes (LNs) are
identified in only 8% to 33% of patients with melanoma who have positive sentinel LNs …

Lymphatic mapping and sentinel lymph node (SLN) biopsy are widely used as a staging
technique for patients with cutaneous malignant melanoma who are at risk for metastases …

A sentinel lymph node (SLN) that is melanoma negative by pathologic examination implies
absence of melanoma metastasis to that regional lymph node field. However, a small …

BACKGROUND The optimal technique for sentinel lymph node (SN) assessment in patients
with melanoma is controversial. Molecular analysis (reverse transcriptase–polymerase …

Background Identification of melanoma patients who need completion lymphadenectomy
and adjuvant treatment after positive sentinel lymph node (SLN) biopsy would be a …

Introduction Sentinel node (SN) biopsy (SNB) and completion lymph node dissection
(CLND) when SN-positive have become standard of care in most cancer centres for …